Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database
Autor
Udovin, Lucas Daniel
Otero-Losada, Matilde
Bordet, Sofia
Chevalier, Guenson
Quarracino, Cecilia
Capani, Francisco
Perez-Lloret, Santiago
Resumen
Introduction: We explored the potential clinical effects of angiotensin-II AT1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) in patients from the Parkinson's Progress Marker Initiative (PPMI) study database. Methods: We included 423 newly diagnosed PD patients, free from antiparkinsonian treatment, from the PPMI. We compared the proportion of patients starting on L-DOPA during the first year of follow-up, and the changes in MDS-UPDRS total score and sub-scores during the first five follow-up years for patients exposed or not to ARBs or ACEIs. Results: Treatment with ARBs did not affect the proportion of patients on L-DOPA during the first year (adjusted OR, 95% CI = 0.26, 0.03–2.18, N.S.) while reduced MDS-UPDRS total score (0.85, 0.76–0.95, p < 0.01). Patients treated with ACEIs experienced no changes in either measure. Conclusions: These results show potential signals for a beneficial effect with ARBs. Further clinical trials are warranted.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Article
Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic (2020)
Otero-Losada, Matilde; Kobiec, Tamara; Udovin, Lucas Daniel; Chevalier, Guenson; Quarracino, Cecilia; Menéndez Maissonave, Camila; Bordet, Sofia; Capani, Francisco; Perez-Lloret, Santiago (Frontiers Media S.A., 2020-09-11) -
Article
The Renin–Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene (2021)
Kobiec, Tamara; Otero-Losada, Matilde; Chevalier, Guenson; Udovin, Lucas Daniel; Bordet, Sofía; Menéndez-Maissonave, Camila; Capani, Francisco; Perez-Lloret, Santiago (Frontiers Media S.A., 2021-04-22)Parkinson’s disease (PD) is an extrapyramidal disorder characterized by neuronal degeneration in several regions of the peripheral and central nervous systems. It is the second most frequent neurodegenerative disease after ... -
Article
Genetics of Neurogenic Orthostatic Hypotension in Parkinson’s Disease, Results from a Cross-Sectional In Silico Study (2024)
Chevalier, Guenson; Udovin, Lucas; Otero-Losada, Matilde; Bordet, Sofia; Capani, Francisco; Luo, Sheng; Goetz, Christopher G.; Perez-Lloret, Santiago (MDPI, 2023)The genetic basis of Neurogenic Orthostatic Hypotension (NOH) in Parkinson’s disease (PD) has been inadequately explored. In a cross-sectional study, we examined the association between NOH and PD-related single-nucleotide ...